866-997-4948(US-Canada Toll Free)

Global Plasminogen Market Professional Survey 2017 Industry Trend and Forecast 2022

Published By :

QYResearch

Published Date : Jun 2017

Category :

Pharmaceutical

No. of Pages : 117 Pages

This report studies the Plasminogen market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Plasminogen market by product type and applications/end industries.


The major players in global Plasminogen market include
Kedrion
Prometic

The major players in global Plasminogen activator market include
Genentech (Roche)
Boehringer Ingelheim
Kyowa Hakko Kirin
Omeros Corporation

Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of Plasminogen in these regions, from 2012 to 2023 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India

On the basis of product, the Plasminogen market is primarily split into
Intravenous Injection
Eye drops

On the basis on the end users/applications, this report covers
Ligneous Conjunctivitis
Diabetic Foot
Wound Healing
Others


Table of Contents

1 Industry Overview of Plasminogen1
1.1 Definition and Specifications of Plasminogen1
1.2 Plasminogen Segment by Types (Product Category)2
1.3 Global Plasminogen Segment by Applications2
1.3.1 Ligneous Conjunctivitis2
1.3.2 Diabetic Foot3
1.3.3 Wounds Healing4
1.4 Orphan Drug Registration of Plasminogen in the Worldwide5
1.5 Global Plasminogen Market by Regions (2017-2023)6
1.5.1 North America Amputation Cost by Diabetic Foot Ulcer Status and Prospect (2017-2023)6
1.5.2 China Amputation Cost by Diabetic Foot Ulcer Status and Prospect (2017-2023)6
1.5.3 Europe Amputation Cost by Diabetic Foot Ulcer Status and Prospect (2017-2023)7
1.5.4 Japan Amputation Cost by Diabetic Foot Ulcer Status and Prospect (2017-2023)9
1.5.5 India Amputation Cost by Diabetic Foot Ulcer Status and Prospect (2017-2023)10
1.5.6 Southeast Asia Amputation Cost by Diabetic Foot Ulcer Status and Prospect (2017-2023)11
1.6 Global Amputation Cost by Diabetic Foot Ulcer Status and Prospect (2017-2023)12
2 Manufacturing Cost Structure Analysis of Plasminogen13
2.1 Raw Material Supply Analysis13
2.1.1 Raw Material and Suppliers13
2.1.2 Global Plasma Analysis13
2.1.3 Numbers of Plasma Collection Stations Analysis16
2.2 Manufacturing Cost Structure Analysis of Plasminogen19
2.2.1 Raw Materials19
2.2.2 Labor Cost20
2.2.3 Manufacturing Expenses22
2.3 Manufacturing Process Analysis of Plasminogen23
2.4 Industry Chain Structure of Plasminogen24
3 Technical Data and Manufacturing Plants Analysis of Plasminogen25
3.1 Capacity and Commercial Production Date of Global Plasminogen Major Manufacturers in 201625
3.2 Manufacturing Plants Distribution of Global Plasminogen Major Manufacturers in 201625
3.3 R&D Status and Technology Source of Global Plasminogen Major Manufacturers in 201626
3.4 Raw Materials Sources Analysis of Global Plasminogen Major Manufacturers in 201626
3.5 Plasma Fractionation Market Analysis27
4 Global Plasminogen Overall Market Overview32
4.1 2012-2017E Overall Market Analysis32
4.2 Capacity Analysis33
5 Plasminogen Regional Market Analysis34
5.1 North America Plasminogen Market Analysis34
5.1.1 North America Plasminogen Market Overview34
5.1.2 North America 2012-2017E Plasminogen Local Consumption Analysis34
5.1.3 North America 2012-2017E Plasminogen Consumption Cost Analysis35
5.1.4 North America 2016 Plasminogen Market Share Analysis36
5.2 China Plasminogen Market Analysis39
5.2.1 China Plasminogen Market Overview39
5.2.2 China 2012-2017E Plasminogen Local Consumption Analysis40
5.2.3 China 2012-2017E Plasminogen Cost Price Analysis40
5.2.4 China 2016 Plasminogen Market Share Analysis40
5.3 Europe Plasminogen Market Analysis42
5.3.1 Europe Plasminogen Market Overview42
5.3.2 Europe 2012-2017E Plasminogen Local Consumption Analysis43
5.3.3 Europe 2012-2017E Plasminogen Cost Price Analysis43
5.3.4 Europe 2016 Plasminogen Market Share Analysis44
5.4 Southeast Asia Plasminogen Market Analysis46
5.4.1 Southeast Asia Plasminogen Market Overview46
5.4.2 Southeast Asia 2012-2017E Plasminogen Local Consumption Analysis46
5.4.3 Southeast Asia 2012-2017E Plasminogen Cost Price Analysis46
5.4.4 Southeast Asia 2016 Plasminogen Market Share Analysis48
5.5 Japan Plasminogen Market Analysis49
5.5.1 Japan Plasminogen Market Overview49
5.5.2 Japan 2012-2017E Plasminogen Local Consumption Analysis50
5.5.3 Japan 2012-2017E Plasminogen Cost Price Analysis50
5.5.4 Japan 2016 Plasminogen Market Share Analysis51
5.6 India Plasminogen Market Analysis52
5.6.1 India Plasminogen Market Overview52
5.6.2 India 2012-2017E Plasminogen Local Consumption Analysis52
5.6.3 India 2012-2017E Plasminogen Cost Price Analysis53
5.6.4 India 2016 Plasminogen Market Share Analysis54
6 Major Manufacturers Analysis of Plasminogen56
6.1 Kedrion56
6.1.1 Company Profile56
6.1.2 Product Description56
6.1.3 Kedrion 2018F Plasminogen Sales, Ex-factory Price, Revenue, Gross Margin Analysis57
6.1.4 Kedrion R&D Progress57
6.1.5 Kedrion Clinical Program58
6.2 Prometic59
6.2.1 Company Profile59
6.2.2 Product Description59
6.2.3 Prometic 2017 Plasminogen Sales, Ex-factory Price, Revenue, Gross Margin Analysis59
6.2.4 Prometic R&D Progress60
6.2.5 Prometic Clinical Program61
7 Major Manufacturers Analysis of Plasminogen Activator Product62
7.1 Genentech (Roche)62
7.1.1 Company Profile62
7.1.2 Product Description63
7.2 Boehringer Ingelheim64
7.2.1 Company Profile64
7.2.2 Product Description64
7.3 Kyowa Hakko Kirin65
7.3.1 Company Profile65
7.3.2 Product Description65
7.4 Omeros Corporation66
7.4.1 Company Profile66
7.4.2 Product Description66
8 Development Trend of Analysis of Plasminogen Market68
8.1 Global Plasminogen Market Trend Analysis68
8.1.1 Global 2018-2023 Plasminogen Market Size (Volume and Value) Forecast68
8.1.2 Global 2018-2023 Plasminogen Treatment Cost Forecast70
8.2 Plasminogen Regional Market Trend71
8.2.1 North America 2018-2023 Plasminogen Consumption Forecast71
8.2.2 China 2018-2023 Plasminogen Consumption Forecast73
8.2.3 Europe 2018-2023 Plasminogen Consumption Forecast75
8.2.4 Southeast Asia 2018-2023 Plasminogen Consumption Forecast77
8.2.5 Japan 2018-2023 Plasminogen Consumption Forecast79
8.2.6 India 2018-2023 Plasminogen Consumption Forecast81
8.3 Plasminogen Market Trend (Product Type)83
8.4 Plasminogen Market Trend83
9 Therapeutic Areas Analysis of Plasminogen84
9.1 Congenital Plasminogen Deficiency Introduction84
9.2 Conjunctivitis Market Analysis84
9.3 Diabetic Foot Market Analysis85
9.4 Sever Burns Market Analysis87
9.5 Wounds Healing Market Analysis87
9.6 Health Expenditure Analysis92
10 Conclusion of the Global Plasminogen Market Professional Survey Report 201698
11 Methodology and Data Source99
11.1 Methodology/Research Approach99
11.1.1 Research Programs/Design99
11.1.2 Market Size Estimation100
11.1.3 Market Breakdown and Data Triangulation101
11.2 Data Source102
11.2.1 Secondary Sources102
11.2.2 Primary Sources103
11.3 Disclaimer104
11.4 Author List105



List of Table

List of Tables and Figures

Figure Plasminogen is Activated to Plasmin by the Plasminogen Activators u-PA and t-PA.1
Table Production Status of Global Plasminogen Major Manufacturers in 20162
Figure Conjunctivitis Examples3
Table Key Participant in Ligneous Conjunctivitis Treatment3
Figure Diabetic Foot Examples3
Table Key Participant in Diabetic Foot Treatment4
Figure Chronic Wounds Examples4
Table Key Participant in Wound Healing Treatment4
Table Orphan Drug Registration of Plasminogen in USA5
Table Orphan Drug Registration of Plasminogen in Europe5
Figure North America Amputation Cost by Diabetic Foot Ulcer (Million USD) and Growth Rate (2017-2023)6
Figure China Amputation Cost by Diabetic Foot Ulcer (Million USD) and Growth Rate (2017-2023)7
Figure Europe Amputation Cost by Diabetic Foot Ulcer (Million USD) and Growth Rate (2017-2023)8
Figure Japan Amputation Cost by Diabetic Foot Ulcer (Million USD) and Growth Rate (2017-2023)9
Figure India Amputation Cost by Diabetic Foot Ulcer (Million USD) and Growth Rate (2017-2023)10
Figure Southeast Asia Amputation Cost by Diabetic Foot Ulcer (Million USD) and Growth Rate (2017-2023)11
Figure Global Amputation Cost by Diabetic Foot Ulcer Status and Prospect (2017-2023)12
Table Plasminogen Raw Material and Suppliers13
Figure Diagram of Automated Plasma Collection Procedure14
Table Global Plasma Volume by Region 2011-2016 (M Liter)14
Table Global Plasma Market Share by Region 2011-201614
Figure Global Plasma Market Share by Region 201615
Table Global Major Manufacturers Plasma volume 2011-2016 (M Liter)15
Table Baxter Plasma volume by Plants 2011-2016 (M Liter)15
Table CSL Plasma volume by Plants 2011-2016 (M Liter)16
Table Grifols Plasma volume by Plants 2011-2016 (M Liter)16
Table Octapharma Plasma by Plants 2011-2016 (M Liter)16
Table Numbers of Blood Collection Stations 2011-201616
Table Baxter Numbers of Blood Collection Stations in USA Switzerland Germany Spain 2011-201617
Table CSL Numbers of Blood collection stations in USA Switzerland Germany Spain 2011-201617
Table Grifols Numbers of Blood collection stations in USA Switzerland Germany Spain 2011-201617
Table Numbers of Blood Collection Stations in USA 2011-201617
Table Numbers of Blood Collection Stations in Switzerland 2011-201618
Table Numbers of Blood Collection Stations in Germany 2011-201618
Table Numbers of Blood Collection Stations in Spain 2011-201618
Table Plasma: Cost Components19
Table Manufacturing Cost Structure Analysis of Plasminogen in 201619
Figure Manufacturing Labor Cost Per Hour in China as a Proportion of Those in Other Countries (%)21
Figure Manufacturing Labor Costs in Select Provinces and Countries in 201521
Figure China Minimum Monthly Wages (CNY/ Month)22
Figure Plasminogen Bulk Manufacturing Flow Chart23
Table Equipment Involves in the Manufacturing23
Table Logistics of Plasminogen Bulk Manufacturing23
Figure Industry Chain Structure of Plasminogen24
Table Production Status of Global Plasminogen Major Manufacturers in 201625
Table Manufacturing Plants Distribution of Global Plasminogen Major Manufacturers in 201625
Table R&D Status and Technology Source of Global Plasminogen Major Manufacturers26
Table Raw Materials Sources Analysis of Global Plasminogen Major Manufacturers26
Figure Constituents of Blood, Plasma, and Plasma Proteins27
Table Specification Comparison of Different Types of Plasma Fractionation27
Figure Global Production Market Share of Plasma Fractionation by Type in 201628
Table Manufacturing Plants Distribution of Global Plasma Fractionation Major Manufacturers in 201628
Table Key Transactions in the Plasma Fractionation Industry, 1997201329
Table Global Consumption Value of Plasma Fractionation by Region 2011-2016 (Million USD)30
Figure Global Consumption Value Market Share of Plasma Fractionation by Region in 201630
Table Global Consumption (Person), Price (USD/Person/year), Sales Revenue (Million USD) and Gross Margin of Plasminogen 2012-201732
Figure Global 2012-2017E Plasminogen Sales (Person) and Growth Rate32
Figure Global 2012-2017E Plasminogen Market Size (Million USD) and Growth Rate33
Figure North America Consumption of Plasminogen 2012-2017 (Number of People)34
Figure North America 2012-2017E Plasminogen Consumption Cost (K USD/People/year)35
Figure Number of Congenital Plasminogen Deficiency Disease in 2012-201736
Figure Number of Diabetic Foot Ulcer with Potential Therapy Demand (Million) in 2012-201737
Figure Typical Diabetic Foot Ulcer Caused by High Plantar Pressures at the Second Metatarsal Head.39
Figure China 2012-2017E Plasminogen Sales Price (custom-made Non batch production) (USD/mg)40
Figure Number of Congenital Plasminogen Deficiency Disease in 2012-201741
Figure Number of Diabetic Foot Ulcer with Potential Therapy Demand (Million) in 2012-201742
Figure Europe 2012-2017E Plasminogen Cost Price (USD/mg)43
Figure Number of Congenital Plasminogen Deficiency Disease in 2012-201744
Figure Top 10 Countries for Diabetes Prevalence in 2010 and 203045
Figure Number of Diabetic Foot Ulcer with Potential Therapy Demand (Million) in 2012-201745
Figure Southeast Asia 2012-2017E Plasminogen Cost Price (USD/mg)47
Figure Number of Congenital Plasminogen Deficiency Disease in 2012-201748
Table Prevalence of diabetes in the WHO South-East Asia Region48
Figure Number of Diabetic Foot Ulcer with Potential Therapy Demand (Million) in 2012-201749
Figure Japan 2012-2017E Plasminogen Cost Price (USD/mg)50
Figure Number of Congenital Plasminogen Deficiency Disease in 2012-201751
Figure Number of Diabetic Foot Ulcer with Potential Therapy Demand (Million) in 2012-201752
Figure India 2012-2017E Plasminogen Cost Price (USD/mg)53
Figure Number of Congenital Plasminogen Deficiency Disease in 2012-201754
Figure Number of Diabetic Foot Ulcer with Potential Therapy Demand (Million) in 2012-201755
Table Kedrion Information List56
Table 2018F Kedrion Plasminogen Revenue, Sales, Ex-factory Price57
Table Study Data Summary58
Table Kedrion Clinical Program Detail58
Table Prometic Information List59
Table ProMetics Plasminogen Pipeline59
Table 2017E Prometic Plasminogen Revenue, Sales, Ex-factory Price59
Figure Estimated Plasma Fractionation Price Types (US$) per Liter of Plasma60
Table Kedrion Clinical Program Detail61
Table Genentech (Roche) Information List62
Figure Product Picture of Activase63
Table Genentech (Roche) Activase Registration63
Table Boehringer Ingelheim Information List64
Figure Product Picture of Actilyse64
Table Boehringer Ingelheim Actilyse Registration64
Table Kyowa Hakko Kirin Information List65
Figure Product Picture of Activacin65
Table Kyowa Hakko Kirin Activacin Registration66
Table Omeros Corporation Information List66
Figure Global 2018-2023 Plasminogen for Conjunctivitis Therapy Sales (Person) and Growth Rate Forecast68
Figure Global 2018-2023 Plasminogen for Conjunctivitis Therapy Market Size (Million USD) and Growth Rate Forecast69
Figure Global 2018-2023 Plasminogen for Conjunctivitis Therapy Treatment Cost (K USD/Personal/Year) Forecast70
Figure North America 2018-2023 Plasminogen for Conjunctivitis Therapy Market and Growth Rate Forecast71
Figure North America 2018-2023 Plasminogen for Conjunctivitis Therapy Consumption Value and Growth Rate Forecast72
Figure North America 2018-2023 Plasminogen Potential Demand in Diabetic Foot Ulcer Patient Forecast (Million People)72
Figure China 2018-2023 Plasminogen for Conjunctivitis Therapy Potential Consumption Volume and Growth Rate Forecast73
Figure China 2018-2023 Plasminogen for Conjunctivitis Therapy Potential Consumption Value and Growth Rate Forecast74
Figure China 2018-2023 Plasminogen Potential Demand in Diabetic Foot Ulcer Patient Forecast (Million People)74
Figure Europe 2018-2023 Plasminogen for Conjunctivitis Therapy Consumption Volume and Growth Rate Forecast75
Figure Europe 2018-2023 Plasminogen for Conjunctivitis Therapy Consumption Value and Growth Rate Forecast76
Figure Europe 2018-2023 Plasminogen Potential Demand in Diabetic Foot Ulcer Patient Forecast (Million People)76
Figure Southeast Asia 2018-2023 Plasminogen Potential Consumption Volume and Growth Rate Forecast77
Figure Southeast Asia 2018-2023 Plasminogen for Conjunctivitis Therapy Potential Consumption Value and Growth Rate Forecast78
Figure Southeast Asia 2018-2023 Plasminogen Potential Demand in Diabetic Foot Ulcer Patient Forecast (Million People)78
Figure Japan 2018-2023 Plasminogen for Conjunctivitis Therapy Potential Consumption Volume and Growth Rate Forecast79
Figure Japan 2018-2023 Plasminogen Potential Consumption Value and Growth Rate Forecast80
Figure Japan 2018-2023 Plasminogen Potential Demand in Diabetic Foot Ulcer Patient Forecast (Million People)80
Figure India 2018-2023 Plasminogen for Conjunctivitis Therapy Potential Consumption Volume and Growth Rate Forecast81
Figure India 2018-2023 Plasminogen Potential Consumption Value and Growth Rate Forecast82
Figure India 2018-2023 Plasminogen Potential Demand in Diabetic Foot Ulcer Patient Forecast (Million People)82
Table Global Consumption Volume (Person) of Plasminogen by Eye drops017-202383
Table Global Consumption Volume (person) of Plasminogen by Age 2018-202383
Figure Global Diabetic Foot Ulcers & Pressure Ulcers Market Revenue (Million USD) in 201687
Figure Picture of Advanced Wound Care88
Figure Global Sales Market Share of Advanced Wound Care by Types in 201689
Figure Global Sales Market Share of Advanced Wound Care by Applications in 201689
Table Global Advanced Wound Care Revenue and Growth Rate (2011-2021)90
Figure Global Advanced Wound Care Revenue and Growth Rate (2011-2021)90
Figure 2016 Global Advanced Wound Care Revenue Share by Manufacturers91
Figure Out-of-pocket Expenditure on Health as a Percentage of Total Expenditure on Health (%) in 201692
Figure Total Expenditure on Health as a Percentage of GDP (%) in 201693
Table USA Health Expenditure Ratios from 1997-201693
Table China Health Expenditure Ratios from 1997-201694
Table Japan Health Expenditure Ratios from 1997-201694
Table Germany Health Expenditure Ratios from 1997-201695
Table UK Health Expenditure Ratios from 1997-201695
Table India Health Expenditure Ratios from 1997-201696
Table Canada Health Expenditure Ratios from 1995-201496
Table Research Programs/Design for This Report99
Figure Bottom-up and Top-down Approaches for This Report101
Figure Data Triangulation102
Table Key Data Information from Secondary Sources103
Table Key Data Information from Primary Sources104

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *